2019 – Page 2 – Melanoma Research Foundation

Press Release

FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...

4 Minute Read

Blogs Events Featured Melanoma News Press Release

December 23, 2019

SMR Christopher J. Marshall Award

Society for Melanoma Research Award – David Olmeda, PhD

1 Minute Read

December 23, 2019

SMR Young Investigator Award

Society for Melanoma Research Award – Carmet Levy, PhD

1 Minute Read

December 20, 2019

Therapeutic Strategies to Induce Dormancy in Disse...

Metastasis is the main cause of melanoma death. Current treatments mostly fail to cure metastasis. It is of common knowledge that disseminated cancer cells (DCCs)...

2 Minute Read

December 20, 2019

Role of PRAME in Epigenetic Reprogramming and Chro...

UM has a propensity to undergo early micrometastasis prior to treatment of the primary tumor, with later emergence of overt metastatic disease. Unfortunately, the...

2 Minute Read

December 20, 2019

Augmenting Melanoma Response to Immunotherapy via ...

Cancer immunotherapy (CI) drugs activate our own immune system to directly kill cancer cells. These drugs have revolutionized how we treat many cancers including melanoma....

2 Minute Read

December 20, 2019

SOX10 Role in WT BRAF Melanoma

Career Development Award – Claudia Capparelli, PhD

1 Minute Read

December 20, 2019

Modulating p53 Transcriptional Activity to Reduce ...

Successful management of melanoma will require eliminating both the primary cancer as well as its spread. The survival of melanoma patients reduces significantly ...

2 Minute Read

December 20, 2019

Pharmacological Targeting of Estrogen Receptor to ...

The development of new classes of drugs which target pathways required for melanoma growth and approaches to increase tumor immunogenicity (Immune Checkpoint Blockade (ICB)...

3 Minute Read

December 20, 2019

Cellular and Genomic Landscape of Uveal Melanoma a...

Uveal melanoma (UM) is a highly aggressive eye cancer that leads to metastatic death in up to half of patients, with no measurable improvement in survival over the past hal...

2 Minute Read

December 20, 2019

The Development and Characterization of Cellular M...

Melanoma is the most aggressive form of skin cancer. Although progress has been made for advanced melanoma patients with 13 new FDA-approved therapies since 2011, resistanc...

3 Minute Read

December 20, 2019

Characterizing the Role of the Hippo Pathway Durin...

The Hippo pathway in cancer, mediated by YAP1, has been implicated in therapy resistance and aggressive tumor behavior in melanomas treated with targeted therapies. However...

1 Minute Read